Introduction {#sec1}
============

The development of more selective and potent pharmaceuticals is one of the most important missions of current organic chemistry. While the process of drug discovery is rather a complicated, multifaceted endeavor, careful structural analysis of the newly approved pharmaceuticals can reveal some essential trends in the successful formulations. For example, introduction of fluorinated groups into a drug candidate molecule usually leads to greater metabolic stability, activity, and overall favorable pharmacokinetics.^[@ref1]^ Another general trend is the incorporation of tailor-made amino acid (AA)^[@ref2]^ moieties allowing for more precise mimicking of peptide--receptor interactions as well as lowering the toxicity and undesirable side effects.^[@ref3]^ Consequently, from the structural standpoint, fluorine-containing α-^[@ref4]^ and β-AAs,^[@ref5]^ featuring both essential traits, are considered to have pronounced pharmaceutical potential in the modern drug design.^[@ref6]^ Chemistry of fluorine-containing AAs and peptides, including synthesis and biological studies, published before 1994, is covered by a comprehensive monograph.^[@ref7]^ Since then, this research field has grown tremendously, being updated by more specialized review articles^[@ref4],[@ref5]^ and recent publications.^[@ref6]^

Among various types of fluorinated tailor-made AAs, linear ω-CF~3~-AAs represent a family of structurally relatively simple, yet very useful compounds widely used in drug development and peptide research.^[@ref8]^ In particular, (*S*)-2-amino-5,5,5-trifluoropentanoic acid (**1**) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), a fluorinated analogue naturally occurring in bacterial proteins norvaline (**2**),^[@ref9]^ has been extensively used in the design of bioactive formulations^[@ref10]^ and protein research.^[@ref11]^ Quite remarkably, the residue of AA **1** played a key role in the development of avagacestat **3**, a γ-secretase inhibitor used in the treatment of Alzheimer disease.^[@ref12]^ As a part of our current activity focused on the large-scale synthesis of a potential pharmaceutical agent, we needed a reliable access to multigram quantities of enantiomerically pure 2-amino-5,5,5-trifluoropentanoic acid **1** derivatives.

![2-Amino-5,5,5-trifluoropentanoic acid (**1**), its naturally occurring parent AA norvaline (**2**), and a γ-secretase inhibitor avagacestat (**3**).](ao-2019-015379_0001){#fig1}

A careful analysis of the literature data available for the preparation of the target AA **1**([@ref13]) evidently indicated that the known approaches are not viable for the large-scale synthesis, prompting us to undertake an appropriate research project. For example, the most operationally convenient and scalable enzymatic resolution approach^[@cit13e]^ produces equal amount of unwanted enantiomer, which would be problematic for the large-scale preparation of only the target enantiomer. On the other hand, the purely chemical approaches for the asymmetric synthesis of AA **1**,^[@cit13d],[@cit13f],[@cit13j]^ while efficient on a small scale, involve chromatographic purifications and strictly controlled reaction conditions, which would be quite problematic for a large-scale process. In this work, we examine two alternative approaches to synthesize AA **1**, including alkylation of a chiral glycine equivalent vs. dynamic kinetic resolution (DKR) of the corresponding racemate. We disclose that the latter approach is significantly more practical, allowing convenient and reliable preparation of the target (*S*)-2-amino-5,5,5-trifluoropentanoic acid (**1**) derivatives on over 20 g scale. The obvious synthetic value of the procedure developed in the present work is that it does not require any special conditions or chromatographic purifications and can be recommended as a method of choice for low-cost, large-scale synthesis.

Results and Discussion {#sec2}
======================

Consistent with our continuous interest in asymmetric synthesis of various types of tailor-made fluorine-,^[@ref14]^ phosphorus-containing,^[@ref15]^ sterically constrained^[@ref16]^ AAs, as well as self-disproportionation of enantiomers^[@ref17]^ of AA derivatives, we are actively developing chemistry of Ni(II) complexes derived from AA Schiff bases^[@cit3e],[@ref18]^ as a general method for the preparation of tailor-made AAs. Using the modular approach for designing chiral tridentate ligands,^[@ref19]^ recently, we introduced strategically tri-chlorosubstituted ligands (*R*)- and (*S*)-**4** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"})^[@ref20]^ possessing the optimized stereocontrolling properties.^[@ref21]^

![Applications of Tridentate Ligand (*S*)-**4** for General Asymmetric Synthesis of α-AAs](ao-2019-015379_0002){#sch1}

[Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}(A) shows the preparation of nucleophilic glycine equivalent (*S*,*S*)-**6**. [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}(B) gives the alkylation of glycine complex (*S*)-**5**. [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}(C) shows the dynamic kinetic resolution of unprotected AAs.

In most of the applications, ligands **4** are first converted to glycine Ni(II) complexes of type **5**, followed by the alkylation of the methylene moiety.^[@ref22]^ A methodologically different approach involves a direct reaction of ligands **4** with racemic AAs, resulting in dynamic kinetic resolution, including (*S*)/(*R*)-interconversion,^[@ref23]^ and formation of major products **6** of (*S*,*S*) absolute configuration.^[@ref24]^ Subsequently, application of (*R*)-configured ligands **4** gives rise to **6**-(*R*,*R*) products, assuming a regular case of CIP priority. It is interesting to note that the dynamic kinetic resolution approach can also be successfully applied for β-AAs.^[@ref25]^ Considering that both approaches can be used for the preparation of the target (*S*)-2-amino-5,5,5-trifluoropentanoic acid (**1**) derivatives, we decided to examine each of them to find the most practical solution.

Alkylation Approach {#sec2.1}
-------------------

Drawing from our recent experience with the alkylation of glycine complex (*S*)-**5** using CF~3~-containing alkyl halides,^[@cit6s]−[@cit6u]^ we decided to use *N*,*N*-dimethyl-formamide (DMF) as a solvent and NaOH as a base for the reaction with 1,1,1-trifluoro-3-iodopropane, as presented in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}.

![Alkylation of Chiral Glycine Equivalent (*S*)-**5**](ao-2019-015379_0003){#sch2}

Analysis of the reaction mixture by thin-layer chromatography and high-performance liquid chromatography revealed the presence of several byproducts including minor diastereomer (*S*)(2*R*)-**7**, bis-alkylated complex (*S*)-**8**, and 4-phenylquinazoline (*S*)-**9**, typical for this reactions.^[@cit6s],[@cit6t]^ As was previously shown,^[@ref26]^ compound (*S*)-**9** is the end product of the reaction of complexes of types **5** and **7** with atmospheric oxygen, leading to the cleavage of the N--C bond, followed by the cyclization involving the proline carbonyl. It should be noted that first attempts to use the conditions optimized for alkylations of (*S*)-**5** with CF~3~--CH~2~--I and CF~3~--(CH~2~)~3~--I^[@cit6s],[@cit6t]^ were rather unsuccessful. Most likely, the application of a base in homogeneous form like NaOMe, solutions, or ground to powder NaOH led to noticeable decomposition of the alkylation reagent due to the favorable formation of CF~3~--CH=CH~2~. Also, in this case, the application of commercial-grade DMF gave unexpectedly higher amounts of oxidation product (*S*)-**9**. Nevertheless, we were able to obtain the undesired reactivity and byproduct formation by using NaOH beads and highly controlled conditions such as dry and deoxygenated DMF. In fact, on the 1 g scale, under these conditions, we obtained rather good chemical yield and diastereoselectivity. Thus, the major diastereomer (*S*,*S*)-**7** was isolated with 98.4% yield and of 84.0% de. Attempts to scale up this procedure were much successful, however. Likely, a problematic homogenization of the reaction mixture, increased decomposition of the alkylating reagent, and difficulties associated with handling larger amounts of solvent and the reagents resulted in deteriorated chemical yields and stereochemical outcome.

Dynamic Kinetic Resolution Approach {#sec2.2}
-----------------------------------

In general, dynamic kinetic resolution (DKR) of unprotected α- and β-AAs using ligands of type (*S*)-**4** is almost ideal methodology for practical large-scale preparation of enantiomerically pure tailor-made AAs.^[@ref23]−[@ref25]^ Nevertheless, one particular limitation of this approach is the availability of starting racemic AA. In our case, the racemic 2-amino-5,5,5-trifluoropentanoic acid is quite inexpensive and commercially available as *N*-acetyl derivative **10** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Preparation of Racemic 2-Amino-5,5,5-trifluoropentanoic Acid Hydrochloride **11**](ao-2019-015379_0004){#sch3}

After a series of experiments, using various conditions to perform a cleavage of the amide bond in **10**, we finally chose 6 N aqueous hydrochloric acid. Thus, heating of amide **10** with 6 N HCl at 100 °C for 4 h led to the desired hydrolysis with quantitative chemical yield. Purification of hydrochloric salt **11** was achieved simply by washing of the crude product and filtration of chemically pure compound **11**, isolated with 88.8% yield.

In contrast to the alkylation procedure, DKR is usually conducted in an alcohol solvent and the process is not complicated by oxidative reactions, leading to the byproducts of type (*S*)-**9**. Accordingly, DKR can be conducted under convenient, not-so-strictly controlled conditions, even in open air, showing a great potential for large-scale synthesis.^[@ref23]−[@ref25]^ As presented in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}, tridentate ligand (*S*)-**4**, used as a hydrochloric salt, was reacted with hydrochloride of 2-amino-5,5,5-trifluoropentanoic acid **11** in methanol in the presence of a base and source of Ni(II) ions to furnish the target product (*S*,*S*)-**7**.

![Dynamic Kinetic Resolution of Racemic Unprotected 2-Amino-5,5,5-trifluoropentanoic Acid Hydrochloride **11**](ao-2019-015379_0005){#sch4}

After a series of reactions conducted to optimize the reaction conditions, it was determined that K~2~CO~3~ and NiCl~2~ were the best-performing base and Ni(II) source, respectively. Of particular importance was the optimization of stoichiometric ratios between all of the reagents. Thus, considering the fact that ligand (*S*)-**4** is more expensive than racemate **11**, we used the latter in excess, calculating the chemical yield based on ligand (*S*)-**4**. The best yield of the product (*S*,*S*)-**7** (97.0%) was obtained with the application of 1.4 equiv excess of *rac*-**11** and NiCl~2~, using 7 equiv of the base. Relatively large excess of K~2~CO~3~ (7 equiv) was needed due to the necessity to neutralize 2 equiv of HCl, transforming both starting ligand (*S*)-**4** and AA *rac*-**11** to a free base and zwitterion, respectively. Most importantly, under these conditions, product (*S*,*S*)-**7** was obtained in a virtually diastereomerically pure form (99.5% de). This aspect of the developed process is of utmost synthetic value, as no other additional purification is required to proceed to the next disassembly stage (vide infra). Furthermore, the isolation of (*S*,*S*)-**7** was achieved simply by filtration of the precipitate formed after pouring of the reaction mixture into aqueous acetic acid. Moreover, we also examined the reproducibility of this method for small- as well as larger-scale reactions. For example, using 16.6 g of ligand (*S*)-**4**, we prepared 38.7 g of (*S*,*S*)-**7** (97% yield, 99.5% de).

The next synthetic step, the disassembly of this prepared product (*S*,*S*)-**7**, is presented in [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}.

![Disassembly of Diastereomer (*S*,*S*)-**7**; Isolation of Free Zwitterionic AA (*S*)-**1**; and Recycling of Ligand (*S*)-**4**](ao-2019-015379_0006){#sch5}

As stated above, product (*S*,*S*)-**7** obtained by the DKR procedure, without any additional purification, was subjected to the disassembly procedure under the action of 3 N HCl in methanol (50 °C for 5 h). Upon disappearance of a typical red--orange color of the Ni(II) complex (*S*,*S*)-**7**, the reaction mixture was allowed to gradually cool down to ambient temperature, resulting in the formation of a precipitate of the hydrochloric salt of ligand (*S*)-**4**. The precipitate was filtered off, allowing for a convenient recycling (∼90%) of the stereochemically intact chiral ligand (*S*)-**4**, which can be reused for the preparation of new batches of AA (*S*)-**1** or other synthetic applications. The target AA (*S*)-**1** was isolated with over 98% yield using a rather standard procedure with cation-exchange resin and 9% ammonium hydroxide as an eluent.

While the isolation of free zwitterionic AA (*S*)-**1** was conceptually important to demonstrate the conventional preparative value of this method, for our development purposes, we needed an access to AA (*S*)-**1** in a form suitable for peptide synthesis. To this goal, we performed a modified disassembly procedure as presented in [Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}.

![Disassembly of Diastereomer (*S*,*S*)-**7**; Isolation of Fmoc-AA (*S*)-**12**; and Recycling of Ligand (*S*)-**4**](ao-2019-015379_0007){#sch6}

First, instead of methanol, we used dimethoxyethane (DME), which improved the solubility of complex (*S*,*S*)-**7**, leading to overall smaller volumes of solvents and a bit greater disassembly rate. The recycling of chiral ligand (*S*)-**4** was achieved by filtration, quite similar to the procedure discussed above ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). The solution of AA (*S*)-**1** with NiCl~2~ was first treated with ethylenediaminetetraacetic acid (EDTA) to chelate the Ni(II) ions, followed by the standard reaction using the Fmoc-OSu reagent under basic conditions. The target Fmoc-derivative (*S*)-**12** was isolated with excellent chemical yield (93.3%) and acceptable enantiomeric purity (98.2% ee).

Finally, it should be noted that the described DKR procedures were also applied for the preparation of (*R*)-2-amino-5,5,5-trifluoropentanoic acid **1** and its Fmoc-derivative **12** using (*R*)-configured chiral ligand **4**.

Conclusions {#sec3}
===========

In this work, we examined two alternative approaches for the preparation of (*S*)-2-amino-5,5,5-trifluoropentanoic acid and its Fmoc-derivative. We found that while the alkylation procedure can be successfully performed on an ∼1 g scale, the dynamic kinetic resolution is generally a more practical solution for scaled up (∼20 g) synthesis. The operational convenience of all chemical transformations coupled with excellent chemical yields and diastereoselectivity, as well as the recycling of the chiral ligand, bodes well for the widespread application of this method.

Experimental Section {#sec4}
====================

Procedure for Alkylation of Chiral Glycine Equivalent (*S*)-**5** {#sec4.1}
-----------------------------------------------------------------

The Ni--Glycine complex (*S*)-**5** (1.0 g, 1.66 mmol) and 1,1,1-trifluoro-3-iodopropane (0.21 mL, 1.83 mmol) were stirred in deoxygenated *N*,*N*-dimethyl-formamide (DMF) (10 mL) at room temperature (rt) under nitrogen. Then, NaOH (beads) (0.080 g, 2.00 mmol) was added into the above mixture. The resulting solution was stirred at room temperature for 2 h and then poured into water (10 mL) and EtOAc (10 mL) at the same temperature. The mixture was separated, and the aqueous layer was extracted with EtOAc (2 × 10 mL). The combined organic layer was washed with brine, dried over Na~2~SO~4~, and then evaporated to afford (*S*,*S*)-**7** (1.14 g, 98.4, 84.0% de).

Preparation of Racemic 2-Amino-5,5,5-trifluoropentanoic Acid Hydrochloride **11** {#sec4.2}
---------------------------------------------------------------------------------

The mixture of Ac-AA **10** (50.4 g, 236 mmol) and 6 N hydrochloric acid aq. (202 mL, 1210 mmol) was heated at 100 °C for 4 h. After the reaction was complete, the reaction mixture was cooled, concentrated, and dried in vacuo at 50 °C for 3 h, in which the compound was loosened for good dryness, to give 50 g of a crude. The crude was ground to a powder as fine as possible and then washed by stirring in acetonitrile (250 mL) for 30 min. The resulting sticky suspension was filtered, washed with acetonitrile (100 mL), and dried in vacuo at 50 °C overnight to afford the AA HCl salt **11** (43.6 g, 88.8%).

**11**: ^1^H NMR (200 MHz, D~2~O): δ 4.12 (t, *J* = 6.2 Hz, 1H), 2.30--2.60 (m, 2H), 2.05--2.30 (m, 2H).

Procedure for the Dynamic Kinetic Resolution of Racemic Unprotected 2-Amino-5,5,5-trifluoropentanoic Acid Hydrochloride **11** {#sec4.3}
------------------------------------------------------------------------------------------------------------------------------

To a mixture of AA HCl salt **11** (16.6 g, 80.1 mmol), ligand (*S*)-**4** (30.0 g, 57.2 mmol), nickel(II) chloride anhydrous (10.4 g, 80.1 mmol), and degassed methanol (900 mL) was added potassium carbonate (55.4 g, 401 mmol). The reaction mixture was stirred at 50 °C for 2.5 h. After the ligand (*S*)-**3** was consumed, the reaction mixture was gradually cooled to around 30 °C and then to 0 °C. The cooled mixture was poured into a cooled acetic acid (45.8 mL, 801 mmol)/distilled water (1800 mL) solution at 0 °C for 30 min to quench and give a precipitate. After stirring for 30 min at 0 °C, the precipitate was filtrated, washed with distilled water, and dried in vacuo at 50 °C overnight to afford the diastereomeric mixture of the Ni(II) complex (*S*,*S*)-**7** (38.7 g, 97.0, 99.5% de).

(*S*,*S*)-**7**: ^1^H NMR (400 MHz, CDCl~3~): δ = 8.90 (d, *J* = 2.0 Hz, 1H), 8.06 (d, *J* = 9.2 Hz, 1H), 7.76 (dd, *J* = 2.0, 8.1 Hz, 1H), 7.48--7.62 (m, 3H), 7.38 (d, *J* = 8.1 Hz, 1H), 7.27--7.31 (m, 1H), 7.14 (dd, *J* = 2.5, 9.2 Hz, 1H), 6.90 (d, *J* = 7.4 Hz, 1H), 6.60 (d, *J* = 2.6 Hz, 1H), 4.33 (d, *J* = 12.5 Hz, 1H), 3.83 (dd, *J* = 3.6, 9.9 Hz, 1H), 3.51--3.57 (m, 2H), 3.39 (dd, *J* = 5.7, 11.1 Hz, 1H), 3.23 (d, *J* = 12.5 Hz, 1H), 2.55--2.76 (m, 3H), 2.22--2.47 (m, 2H), 1.95--2.17 (m, 2H), 1.76--1.89 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ = 23.9, 28.2 (*J* = 3.0 Hz, d), 30.1 (*J* = 29.0 Hz, q), 30.8, 58.4, 63.1, 68.8, 71.2, 124.3, 125.9, 126.3 (*J* = 275.0 Hz, q), 126.9, 127.0, 127.1, 129.5, 129.5, 129.9, 130.5, 131.1, 132.2, 132.4, 132.7, 133.4, 133.6, 134.8, 140.6, 171.0, 177.9, 180.0. ^19^F NMR (376 MHz, CDCl~3~): δ = −67.6 (CF~3~). IR (KBr): ν = 2962, 2867, 1678, 1647, 1534, 1464, 1397, 1250, 1166, 1077, 822 cm^--1^. MS (ESI): *m*/*z* = 718.0 \[M + Na\]^+^.

Procedure for Disassembly of Diastereomer (*S*,*S*)-**7**; Isolation of Free Zwitterionic AA (*S*)-**1**; and Recycling of Ligand (*S*)-**4** {#sec4.4}
---------------------------------------------------------------------------------------------------------------------------------------------

To a suspension of the Ni(II) complex (*S*,*S*)-**7** (33.6 g, 48.2 mmol) in methanol (336 mL) was added 3 N hydrochloric acid aq. (80 mL, 240 mmol), and the whole mixture was heated at 50 °C for 5 h. After the completion of the reaction, the mixture was cooled to ambient temperature. The resulting precipitate was collected by filtration (recovered ligand (*S*)-**4**), and the filtrate was concentrated. CH~2~Cl~2~ (250 mL) and H~2~O (200 mL) were added to the residue, and then the mixture was separated. The aqueous layer was evaporated in vacuo to the residue, which was dissolved in minimum amount of 9% ammonium hydroxide and loaded onto a cation-exchange resin column using DIAION SK-1B (Mitsubishi Chemical Co., 440 mL). The column was first washed with deionized water until neutral, followed by 9% ammonium hydroxide to elute the desired amino acid. The aqueous solution obtained was evaporated to afford AA (*S*)-**1** (8.34 g, quant., 99.2% ee).

(*S*)-**1**: ^1^H NMR (200 MHz, CD~3~OD): δ = 3.60 (t, *J* = 6.1 Hz, 1H), 2.16--2.57 (m, 2H), 1.96--2.16 (m, 2H).

Procedure for Disassembly of Diastereomer (*S*,*S*)-**7**; Isolation of Fmoc-AA (*S*)-**12**; and Recycling of Ligand (*S*)-**4** {#sec4.5}
---------------------------------------------------------------------------------------------------------------------------------

To a suspension of the Ni(II) complex (*S*,*S*)-**7** (38.5 g, 55.2 mmol) in 1,2-dimetoxyethane (193 mL) was added 3 N hydrochloric acid aq. (92.0 mL, 276 mmol), and the whole mixture was heated at 50 °C for 3 h. After the completion of the reaction, the mixture was cooled to ambient temperature. The resulting precipitate was collected by filtration (1st recovered ligand (*S*)-**3**), and the filtrate was concentrated to remove 1,2-dimetoxyethane and give a white solid in a green solution. The suspension was stirred at rt for 2 h and filtered to separate the solid (2nd recovered ligand (*S*)-**4**). The filtrate was concentrated as much as possible to give AA (*S*)-**1** as a green muddy solid (38.8 g, theoretically 9.44 g of amino acid). To the solid were added distilled water (47 mL), ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate (20.5 g, 55.2 mmol), and acetonitrile (27 mL), and the whole mixture was stirred at rt for 30 min. After cooling to 0 °C, the mixture was basified with sodium carbonate to pH over 8. After stirring at 0 °C for 10 min, to this heterogeneous solution was added a suspension of *N*-(9-fluorenylmethoxycarbonyloxy)succinimide (Fmoc-OSu) (18.6 g, 55.2 mmol) in acetonitrile (20 mL) and stirred at rt for 4 h with the pH over 8 by addition of sodium carbonate. After evaporation of the organic solvent, to the aqueous residue was added ethyl acetate (47 mL). The mixture was acidified with 6 N HCl to pH 1 to give a precipitate that dissolved with another ethyl acetate (47 mL). After the separation of an organic layer and an aqueous layer, the aqueous layer was extracted with ethyl acetate (x3). The combined organic layers were washed with water and brain and dried over sodium sulfate. The organic solution was concentrated to afford crude Fmoc-AA (*S*)-**12**. The crude solid was recrystallized from ethyl acetate/heptane (1:30, 1350 mL) and dried in vacuo at 50 °C to afford Fmoc-AA (*S*)-**12** (20.2 g, 93.3, 98.2% ee).

**12**: ^1^H NMR (400 MHz, CD~3~OD): δ 7.78 (2H), 7.67 (2H), 7.36 (2H), 7.29 (2H), 4.36 (2H), 4.19 (2H), 2.35--1.82 (m, 4H). ^19^F NMR (376 MHz, CDCl~3~): δ = −66.86 (CF~3~). MS (ESI): *m*/*z* = 416 \[M + Na\]^+^.
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